{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:31Z","timestamp":1782722731637,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xkme.2026.101380","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:43:36Z","timestamp":1777603416000},"page":"101380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab"],"prefix":"10.1016","volume":"8","author":[{"given":"Lucas","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Badot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Nagant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ghorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Bienfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Nortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-9716","authenticated-orcid":false,"given":"Maxime","family":"Taghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101380_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101380_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2215\/CJN.0000000000000438","article-title":"Nonlupus full house nephropathy: a systematic review","volume":"19","author":"Uzzo","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101380_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/gfw230","article-title":"Outcome of childhood-onset full-house nephropathy","volume":"32","author":"Ruggiero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101380_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ndt\/gfx020","article-title":"Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome","volume":"32","author":"Rijnink","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2026.101380_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004670050416","article-title":"Systemic juvenile rheumatoid arthritis complicated by two different renal lesions","volume":"12","author":"Foster","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2026.101380_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/PL00011196","article-title":"Renal involvement in juvenile rheumatoid arthritis: report of two cases","volume":"20","author":"Gedalia","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.xkme.2026.101380_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1759720X12455960","article-title":"Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis","volume":"4","author":"Yokota","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.xkme.2026.101380_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/rheumatology\/34.5.454","article-title":"Inflammatory cytokine responses in juvenile chronic arthritis","volume":"34","author":"Rooney","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.xkme.2026.101380_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.xkme.2026.101380_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13075-017-1462-2","article-title":"Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry","volume":"19","author":"Horneff","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.xkme.2026.101380_bib11","first-page":"S71","article-title":"Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis","volume":"39","author":"Horii","year":"1993","journal-title":"Kidney Int Suppl"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:06:58Z","timestamp":1782720418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952600141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S259005952600141X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101380","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101380"}}